Role Of Endothelial-Mesenchymal Transition In The Tumorigenesis Of Infantile Hemangioma
Wen-Ping Yang,Yu Zhang,Yue Su,Zao-Hui Cao,Jia-Shu He,Yuan Chen,Si-Yao Zhang,Zhen Li,Fei Tong,Hui Huang,Meng-Meng Wang,Hui Xu,Wei Xu,Yan-Juan Deng,Jian Sun,Xiao-Liang Lou,Nan-Ping Chen,Jin-Ping Hu,Lv Zhou,Hai-Bo Liu,Yue-Yan Li,Rong Wang,Huan Deng
2017-01-01
Abstract:The aim of this study was to investigate the relationship between endothelial-mesenchymal transition (EndoMT) and the progression of infantile hemangioma (IH) and to provide references for clinical. Sixty-five patients were enrolled in this study. Tissues obtained from these patients were analyzed by tissue microarray (TMA). Serial sections from TMA blocks underwent immunohistochemistry with the primary antibodies for EndoMT markers (Twist, Zeb1, Smad, N-cadherin, Vimentin, and alpha-SMA). Intensity and extent points were counted to quantitate the markers expression. All sixty-five patients were diagnosed as IH, which distributes all over the body from head to planta pedis. Progressive phases could be distinguished with H&E staining. The expressionof Twist, Zeb1, Smad, a-SMA, Vimentin and N-cadherin in the abnormal endothelial cells were significantly increased compared with normal controls (***P < 0.01). Average expression points (intensity + extent) in proliferating and involuting phases were 7.69 and 7.80 for Twist; 8 and 7.90 for Zeb1; 4.43 and 3.80 for N-cadherin; 6.72 and 6.85 for Smad; 7.31 and 6.87 for alpha-SMA, and 6.42 and 7.00 for Vimentin. EndoMT involves in the tumorigenesis of IH. The endothelial cells have the capacity to transdifferentiate into mesenchymal cells when IH proliferates and these mesenchymal cells may further transdifferentiate into adipocytes or fibroblasts in involuting phase.